Even though we used different backgrounds of PAH, namely, ASD-PAH and ASD without PH as controls, and the type of adrenomedullin measured in our study differs from those previously reported, since we measured the bioactive adrenomedullin or bio-ADM, the results from previously mentioned studies could still be confirmed. The gene discussed is ADM; the disease is pulmonary arterial hypertension.